Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

08 March 2002

Patient acceptance and reliability of new Humulin/Humalog 3.0 ml pre-filled insulin pen in ten Croatian diabetes centres.

John Wyatt, Nadia Mincheva, Ante Petrusic, Ante Ivandic, Tomislav Cabrijan, Eduard Galic, Mate Sucic, Zvonko Milicevic, James Malone

Med Sci Monit 2002; 8(3): PI21-26 :: ID: 420916

Abstract

BACKGROUND: The objective of this study was to assess feature preferences,patient acceptance, reliability, and safety of the new Lilly Humulin/Humalog 3.0 ml prefilled insulinpen in a clinical setting. MATERIAL/METHODS: A total of 330 patients in Croatia with type 1 or type 2diabetes mellitus who required at least one injection of insulin per day were treated with Humulin 30/70or Humalog for 4 to 6 weeks using the new prefilled pen. Questionnaires concerning various aspects ofthe pen performance were administered at endpoint. RESULTS: The features of the Lilly 3.0 ml pen deviceranked most highly by patients (% of excellent or good ratings) were cartridge visibility (93%), attaching/replacingneedles (93%), ease of dose correction (92%), checking insulin flow (90%) and dialling of insulin dose(89%). Features of the pen device rated most highly by patients in comparison with the delivery systemsused before the study and the percentage of patients rating those features as much better or better wereease of dose correction (74%), cartridge visibility (67%), audible dialing clicks (55%) and size of dosenumbers (52%). Most respondents (78%) preferred single-unit versus two-unit dosage increments. The majorityof patients rated the new prefilled pen as being more convenient and easier to use, and indicated thatit represented a significant or modest an improvement over their previous insulin injection method. CONCLUSIONS:The results of this study indicate that the new Lilly 3.0 ml prefilled pen is acceptable for patientswho were previously using either reusable devices or the traditional syringe and vial.

Keywords: Adolescent, Aged, 80 and over, Croatia, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Equipment Design, Injections, Insulin, Patient Compliance, Patient Education, Patient Satisfaction, Questionnaires, Reproducibility of Results, Syringes

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750